Pembrolizumab for Advanced Cancer in Children

A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)

Recruiting Phase 1 Phase 2 Interventional Study
Melanoma Lymphoma Solid Tumor Classical Hodgkin Lymphoma Microsatellite-instability-high Solid Tumor
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Prior Safety Data This treatment has already been tested in at least one earlier human trial.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
6 Months – 17
Sex
Any
Trial phase
Phase 1/2
Study type
Interventional
Purpose
Treatment
Participants needed
370 (estimated)
Sponsor
Merck Sharp & Dohme LLC · Industry
Who this trial is looking for

This trial is looking for children with advanced solid tumors or lymphomas that are hard to treat. Participants will receive a medication called pembrolizumab to see if it helps shrink or eliminate their cancer.

Are You a Good Fit for This Trial?
Rules you out Active central nervous system metastasesActive autoimmune diseaseHIVHepatitis B or CTuberculosis

You may be able to join if

  • I am between 6 months and 17 years old.
  • I have a solid tumor or lymphoma that is advanced or has not responded to treatment.
  • I have measurable cancer that can be assessed.
  • I have had previous cancer treatments.
  • I have a sample of my tumor available for testing.
  • I have good organ function.
  • I am not pregnant or breastfeeding.

You may not be able to join if

  • I have taken any investigational treatments in the last 4 weeks.
  • I have an active infection requiring treatment.
  • I have had prior cancer treatment in the last 2 weeks.
  • I have a known immune disorder or am taking steroids.
  • I have any current brain cancer or tumors affecting my brain stem.
  • I have had a severe allergic reaction to pembrolizumab.
  • I have a history of certain serious lung issues.
  • I am currently pregnant or planning to become pregnant.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial
Researchers are looking for new ways to treat children with different types of melanoma (skin cancer), solid tumors, and lymphomas (blood cancers) that are any of these: * Advanced, which means cancer spread in the body or cannot be removed with surgery * Relapsed, which means cancer has come back after it had responded to previous treatment (responded means it stopped growing, gets smaller, or d…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Between 6 months and \<18 years of age on day of signing informed consent is documented. * Histologically- or cytologically-documented, locally-advanced, or metastatic solid malignancy or lymphoma that is incurable and has failed prior standard therapy, or for which no standar…
Contacts

Toll Free Number

1-888-577-8839

Trialsites@msd.com

CONTACT